Literature DB >> 30092156

Reactivation of human herpesviruses 6 and 7 in Kawasaki disease.

Yoshihiko Kawano1, Jun-Ichi Kawada2, Noriko Nagai1, Yoshinori Ito2.   

Abstract

Objectives: Kawasaki disease (KD) is one of the most common childhood vasculitides. Some serological studies have suggested an etiological relationship between KD and human herpesvirus (HHV)-6 or HHV-7. However, primary or reactivated HHV-6 and -7 has not been fully investigated in patients with KD.
Methods: Twenty-three patients with KD were prospectively enrolled in this study. Peripheral blood was collected in the acute and convalescence phases, and HHV-6 and -7 viral loads were measured by real-time PCR.
Results: In the acute phase, HHV-6 and -7 DNA was detected in 7 (30%) patients each, compared to 13 (57%) and 9 (39%) patients in the convalescence phase, respectively. HHV-6 and -7 DNA loads were significantly higher in the convalescence phase than in the acute phase. Significant increases in HHV-6 and -7 DNA loads were not observed in disease control patients. Taking into account HHV-6 and -7 serostatus, reactivation of HHV-6 and -7 was observed in 7 and 9 patients, respectively. KD patients with HHV-6 reactivation showed higher C-reactive protein levels and more frequently required steroid therapies than patients without reactivation.
Conclusion: HHV-6 and -7 reactivation is frequent in KD patients. HHV-6 reactivation might exacerbate the severity of KD.

Entities:  

Keywords:  Human herpesvirus 6; Kawasaki disease; human herpesvirus 7

Mesh:

Substances:

Year:  2018        PMID: 30092156     DOI: 10.1080/14397595.2018.1510758

Source DB:  PubMed          Journal:  Mod Rheumatol        ISSN: 1439-7595            Impact factor:   3.023


  5 in total

Review 1.  Kawasaki-like diseases and thrombotic coagulopathy in COVID-19: delayed over-activation of the STING pathway?

Authors:  Jean-Marie Berthelot; Ludovic Drouet; Frédéric Lioté
Journal:  Emerg Microbes Infect       Date:  2020-12       Impact factor: 7.163

2.  Presence and clinical impact of human herpesvirus-6 infection in patients with moderate to critical coronavirus disease-19.

Authors:  Katia Lino; Lilian S Alves; Jessica V Raposo; Thalia Medeiros; Cintia F Souza; Andrea A da Silva; Vanessa S de Paula; Jorge R Almeida
Journal:  J Med Virol       Date:  2021-10-19       Impact factor: 20.693

3.  Incomplete Kawasaki Disease Associated With Human Herpes Virus-6 Variant B Infection and Aseptic Meningitis.

Authors:  Morouge M Alramadhan; Ankur A Kamdar; Meaghan Lafferty-Prather; Elizabeth A Aguilera; Susan H Wootton
Journal:  Glob Pediatr Health       Date:  2020-07-25

4.  The clinics of HHV-6 infection in COVID-19 pandemic: Pityriasis rosea and Kawasaki disease.

Authors:  Recep Dursun; Selami Aykut Temiz
Journal:  Dermatol Ther       Date:  2020-06-29       Impact factor: 3.858

5.  Comprehensive pathogen detection in sera of Kawasaki disease patients by high-throughput sequencing: a retrospective exploratory study.

Authors:  Yuka Torii; Kazuhiro Horiba; Satoshi Hayano; Taichi Kato; Takako Suzuki; Jun-Ichi Kawada; Yoshiyuki Takahashi; Seiji Kojima; Yusuke Okuno; Tomoo Ogi; Yoshinori Ito
Journal:  BMC Pediatr       Date:  2020-10-15       Impact factor: 2.125

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.